Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Pre Market
Current status date:
2019-04-10
Original market date: See footnote 1
Product name:
LIDOCAINE HYDROCHLORIDE 0.5% AND EPINEPHRINE 1:200000 INJECTION USP
Description:
WITH PRESERVATIVE. 50ML MULTIDOSE VIAL
DIN:
02439425
Product Monograph/Veterinary Labelling:
Date:
2015-03-26
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
HOSPIRA HEALTHCARE ULC
17300 Trans-Canada Highway
Kirkland
Quebec
Canada
H9J 2M5
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Block/Infiltration
Number of active ingredient(s):
2
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
72:00.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
N01BB52 LIDOCAINE, COMBINATIONS
Active ingredient group (AIG) number:See footnote5
0201284007
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| EPINEPHRINE | 0.005 MG / ML |
| LIDOCAINE HYDROCHLORIDE | 5 MG / ML |